Cargando…

Evaluation of protein biomarkers of prostate cancer aggressiveness

BACKGROUND: Prognostic multibiomarker signatures in prostate cancer (PCa) may improve patient management and provide a bridge for developing novel therapeutics and imaging methods. Our objective was to evaluate the association between expression of 33 candidate protein biomarkers and time to biochem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rizzardi, Anthony E, Rosener, Nikolaus K, Koopmeiners, Joseph S, Isaksson Vogel, Rachel, Metzger, Gregory J, Forster, Colleen L, Marston, Lauren O, Tiffany, Jessica R, McCarthy, James B, Turley, Eva A, Warlick, Christopher A, Henriksen, Jonathan C, Schmechel, Stephen C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101830/ https://www.ncbi.nlm.nih.gov/pubmed/24708576 http://dx.doi.org/10.1186/1471-2407-14-244

Ejemplares similares

Development of Multigene Expression Signature Maps at the Protein Level from Digitized Immunohistochemistry Slides
por: Metzger, Gregory J., et al.
Publicado: (2012)

Signature maps for automatic identification of prostate cancer from colorimetric analysis of H&E- and IHC-stained histopathological specimens
por: Leng, Ethan, et al.
Publicado: (2019)

Quantitative comparison of immunohistochemical staining measured by digital image analysis versus pathologist visual scoring
por: Rizzardi, Anthony E, et al.
Publicado: (2012)

4159 Prostate cancer multiparametric MRI comparison study of 3T versus 7T in terms of lesion detection and image quality
por: Leng, Ethan, et al.
Publicado: (2020)

Quantitative comparison and reproducibility of pathologist scoring and digital image analysis of estrogen receptor β2 immunohistochemistry in prostate cancer
por: Rizzardi, Anthony E., et al.
Publicado: (2016)

Expression of FAP, ADAM12, WISP1, and SOX11 is heterogeneous in aggressive fibromatosis and spatially relates to the histologic features of tumor activity
por: Misemer, Benjamin S, et al.
Publicado: (2014)

Racial disparities and considerations for active surveillance of prostate cancer
por: Jiang, Song, et al.
Publicado: (2018)

Hyaluronan, Cancer-Associated Fibroblasts and the Tumor Microenvironment in Malignant Progression
por: McCarthy, James B., et al.
Publicado: (2018)

Corrigendum: Hyaluronan, Cancer-Associated Fibroblasts and the Tumor Microenvironment in Malignant Progression
por: McCarthy, James B., et al.
Publicado: (2018)

Biomarkers of Aggressive Prostate Cancer at Diagnosis
por: Boehm, Brock E., et al.
Publicado: (2023)

The Use of Magnetic Resonance Imaging in the Prostate Cancer Primary Diagnostic Pathway: Is It Ready for Primetime?
por: Sathianathen, Niranjan J., et al.
Publicado: (2018)

Hyaluronan and RHAMM in Wound Repair and the “Cancerization” of Stromal Tissues
por: Tolg, Cornelia, et al.
Publicado: (2014)

RHAMM Is a Multifunctional Protein That Regulates Cancer Progression
por: Messam, Britney J., et al.
Publicado: (2021)

Los campesinos en la Edad Media
por: Rösener, Werner
Publicado: (1990)

Association of prostate volume with incidence and aggressiveness of prostate cancer
por: Al-Khalil, Shadi, et al.
Publicado: (2016)

MRI grading for the prediction of prostate cancer aggressiveness
por: Boschheidgen, M., et al.
Publicado: (2021)

Los campesinos en la historia europea
por: Rösener, Werner, 1944-
Publicado: (1995)

Neuroendocrine and Aggressive-Variant Prostate Cancer
por: Spetsieris, Nicholas, et al.
Publicado: (2020)

Mitochondrial mutations drive prostate cancer aggression
por: Hopkins, Julia F., et al.
Publicado: (2017)

Serum Fucosylated Prostate-specific Antigen (PSA) Improves the Differentiation of Aggressive from Non-aggressive Prostate Cancers
por: Li, Qing Kay, et al.
Publicado: (2015)

Hyaluronan, Inflammation, and Breast Cancer Progression
por: Schwertfeger, Kathryn L., et al.
Publicado: (2015)

The Content and Size of Hyaluronan in Biological Fluids and Tissues
por: Cowman, Mary K., et al.
Publicado: (2015)

Hyaluronan Functions in Wound Repair That Are Captured to Fuel Breast Cancer Progression
por: Tolg, Cornelia, et al.
Publicado: (2021)

Defining aggressive prostate cancer: a geospatial perspective
por: Wiese, Daniel, et al.
Publicado: (2023)

Upregulation of SATB1 Is Associated with Prostate Cancer Aggressiveness and Disease Progression
por: Shukla, Sanjeev, et al.
Publicado: (2013)

Impact of a Mechanism-Based Anti-Aggression Psychotherapy on Behavioral Mechanisms of Aggression in Patients With Borderline Personality Disorder
por: Honecker, Hannah, et al.
Publicado: (2021)

Isolated Hepatic Metastasis from Prostate Carcinoma
por: Wang, Stephani C., et al.
Publicado: (2016)

Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer
por: Mazzu, Ying Z., et al.
Publicado: (2020)

Large-Scale Functional Brain Networks of Maladaptive Childhood Aggression Identified by Connectome-Based Predictive Modeling
por: Ibrahim, Karim, et al.
Publicado: (2022)

Potential human health effects associated with laboratory exposures to Pfiesteria piscicida.
por: Schmechel, D E, et al.
Publicado: (2001)

Depressive symptoms and anger and aggression in Russian adolescents
por: Ruchkin, Vladislav, et al.
Publicado: (2023)

Blood-Based Biomarkers of Aggressive Prostate Cancer
por: Liong, Men Long, et al.
Publicado: (2012)

Src: Marker or Actor in Prostate Cancer Aggressiveness
por: Vlaeminck-Guillem, Virginie, et al.
Publicado: (2014)

Serum lipid profiles and aggressive prostate cancer
por: Li, Yanjing, et al.
Publicado: (2015)

Aggressive angiomyxoma of the prostate: A case report
por: Zhu, Zhirong, et al.
Publicado: (2018)

ANO7 is associated with aggressive prostate cancer
por: Kaikkonen, Elina, et al.
Publicado: (2018)

Urinary glycoproteins associated with aggressive prostate cancer
por: Dong, Mingming, et al.
Publicado: (2020)

Genomic analysis of aggressive ductal adenocarcinoma of the prostate
por: Kobayashi, Hiroaki, et al.
Publicado: (2022)

Leukocyte telomere length is associated with aggressive prostate cancer in localized prostate cancer patients
por: Xu, Junfeng, et al.
Publicado: (2020)

Two Susceptibility Loci Identified for Prostate Cancer Aggressiveness
por: Berndt, Sonja I., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_r5j5211d6dhmrg333mef742bom